Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Chronic Insomnia
- Main trialPhase 2
- “The goal of this clinical trial is to learn if SOM001 is safe and well tolerated in adults with insomnia. It will also evaluate if it helps to improve sleep. The main questions this trial aims to answer are: 1. Is SOM001 associated with any side-effects 2. Do people tolerate SOM001 well 3. Is SOM001 helpful to improve sleep Researchers will compare SOM001 to a placebo (a look-alike substance that contains no drug) as well as to 2 other well-established medications that are often used to treat sleep. Participants will: 1. Take one of the drugs, or placebo for 3 nights each week, for 3…”In the company’s words, NCT07920185 on ClinicalTrials.gov
Other drugs for Chronic Insomnia
- RamelteonNanjing Chia-tai Tianqing Pharmaceutical · Phase 3
- SolriamfetolAxsome Therapeutics, Inc. · Phase 3
- SuvorexantMerck & Co. · Phase 3
- CBD TPMAvecho Biotechnology · Phase 3
- TasimelteonVanda Pharmaceuticals · Phase 3
- HS-10506Hansoh · Phase 3
Coming up1
- 1 Oct 2027Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Not yet recruiting | 1 Oct 2027 | A Study of Oral SOM001 as a Safe and Effective Treatment for Adults With Chronic Insomnia |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026